Skip to main content

What the label lists and what reports show

Arsenic trioxide side effects

Arsenic trioxide's FDA label: “The most common adverse reactions (> 30%) are nausea, cough, fatigue, pyrexia, headache, abdominal pain, vomiting, tachycardia, diarrhea, dyspnea, hypokalemia, leukocytosis, hyperglycemia, hypomagnesemia, insomnia, dermatitis, edema, QTc prolongation, rigors …” FAERS holds 1,138 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is differentiation syndrome (189 reports).

  • Generic listed
  • A presentation discontinued
  • Boxed warning

Check it at the source: the arsenic trioxide FDA label on DailyMed (effective July 23, 2021, Amneal Pharmaceuticals LLC); the FDA FAERS public dashboard.

What does the label list?

From the label: adverse reactions

The most common adverse reactions (> 30%) are nausea, cough, fatigue, pyrexia, headache, abdominal pain, vomiting, tachycardia, diarrhea, dyspnea, hypokalemia, leukocytosis, hyperglycemia, hypomagnesemia, insomnia, dermatitis, edema, QTc prolongation, rigors, sore throat, arthralgia, paresthesia, and pruritus.

Table 4: Adverse Reactions (≥ 5%) in Patients with Relapsed or Refractory APL Who Received Arsenic Trioxide Injection in Study PLRXAS01

This table is printed in the Arsenic Trioxide label published by Fresenius Kabi USA, LLC of August 21, 2025; the label quoted above does not print one.

Body System Adverse reactionAny Grade Adverse ReactionsGrade ≥3 Adverse Reactions
Nausea3075
Vomiting2358
Diarrhea2153
Sore throat1435
Anorexia923
Appetite decreased615
Loose stools410
Dyspepsia410
Oral blistering38
Fecal incontinence38
Gastrointestinal hemorrhage38
Dry mouth38
Abdominal tenderness38
Diarrhea hemorrhagic38
Abdominal distension38
Cough2665
Epistaxis1025
Post nasal drip513
Wheezing513
Decreased breath sounds410
Crepitations410
Rales410
Hemoptysis38
Tachypnea38
Rhonchi38

Rows and numbers as the label prints them, under its own column headings (the first rows of a longer table where it runs on). A reaction in a trial table is not necessarily caused by the medicine, and trials differ from everyday use.

From the label: adverse reactions, continued

The following clinically significant adverse reactions are described elsewhere in the labeling: Differentiation Syndrome [see Warnings and Precautions (5.1) ] Cardiac Conduction Abnormalities [see Warnings and Precautions (5.2) ] Encephalopathy [see Warnings and Precautions (5.3) ] Hepatotoxicity [see Warnings and Precautions (5.4) ] Carcinogenesis [see Warnings and Precautions (5.5) ] The most common adverse reactions (> 30%) are nausea, cough, fatigue, pyrexia, headache, abdominal pain, vomiting, tachycardia, diarrhea, dyspnea, hypokalemia, leukocytosis, hyperglycemia, hypomagnesemia, insomnia, dermatitis, edema, QTc prolongation, rigors, sore throat, arthralgia, paresthesia, and pruritus. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Amneal Pharmaceuticals at 1-877-835-5472 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. Relapsed or Refractory APL Safety information was available for 52 patients with relapsed or refractory APL who participated in clinical trials of arsenic trioxide. …

Source: FDA drug label, Amneal Pharmaceuticals LLC, effective July 23, 2021 (SPL set 5845022e-8c01-451b-ae49-a28e58c5f845), via openFDA; the full label on DailyMed

What do FAERS reports show?

1,138 reports list arsenic trioxide among the medicines taken, each a report of something that happened, not proof the medicine caused it; 145 are coded as a death and 400 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Of the 21 reactions below, 12 are named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.

Reports received each year

The 25 most reported reactions

  • Differentiation Syndrome (named in the label)189
  • Off Label Use (a use or a product term, not a reaction)148
  • Electrocardiogram Qt Prolonged113
  • Drug Ineffective (a use or a product term, not a reaction)67
  • Idiopathic Intracranial Hypertension44
  • Pyrexia (named in the label)41
  • Acute Kidney Injury39
  • Fatigue (named in the label)35
  • Neutropenia (named in the label)35
  • Thrombocytopenia (named in the label)35
  • Anaemia (named in the label)33
  • Diarrhoea (named in the label)33
  • White Blood Cell Count Increased33
  • Febrile Neutropenia (named in the label)31
  • Pneumonia31
  • Acute Promyelocytic Leukaemia Differentiation Syndrome29
  • Dyspnoea (named in the label)29
  • Respiratory Failure29
  • Hypotension (named in the label)28
  • Death (an outcome recorded in the report)27
  • Nausea (named in the label)27
  • Product Use In Unapproved Indication (a use or a product term, not a reaction)27
  • Leukaemia Recurrent26
  • Pericarditis25
  • Vomiting (named in the label)25

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms

What next?

Arsenic trioxide: the full record
label, generics, price, shortages, recalls
Side effects hub
the most reported medicines and reactions